Abstract:Alcoholic liver disease (ALD) is characterized by lipid accumulation and liver injury. However, how chronic alcohol consumption causes hepatic lipid accumulation remains elusive. The present study demonstrates that activation of the mechanistic target of rapamycin complex 1 (mTORC1) plays a causal role in alcoholic steatosis, inflammation, and liver injury. Chronic‐plus‐binge ethanol feeding led to hyperactivation of mTORC1, as evidenced by increased phosphorylation of mTOR and its downstream kinase S6 kinase 1 (S6K1) in hepatocytes. Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain‐containing mTOR‐interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide–dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic‐plus‐binge ethanol‐fed mice and in the liver of patients with ALD. Conversely, adenoviral overexpression of hepatic DEPTOR suppressed mTORC1 signaling and ameliorated alcoholic hepatosteatosis, inflammation, and acute‐on‐chronic liver injury. Mechanistically, the lipid‐lowering effect of hepatic DEPTOR was attributable to decreased proteolytic processing, nuclear translocation, and transcriptional activity of the lipogenic transcription factor sterol regulatory element‐binding protein‐1 (SREBP‐1). DEPTOR‐dependent inhibition of mTORC1 also attenuated alcohol‐induced cytoplasmic accumulation of the lipogenic regulator lipin 1 and prevented alcohol‐mediated inhibition of fatty acid oxidation. Pharmacological intervention with rapamycin alleviated the ability of alcohol to up‐regulate lipogenesis, to down‐regulate fatty acid oxidation, and to induce steatogenic phenotypes. Chronic‐plus‐binge ethanol feeding led to activation of SREBP‐1 and lipin 1 through S6K1‐dependent and independent mechanisms. Furthermore, hepatocyte‐specific deletion of SIRT1 disrupted DEPTOR function, enhanced mTORC1 activity, and exacerbated alcoholic fatty liver, inflammation, and liver injury in mice. Conclusion: The dysregulation of SIRT1–DEPTOR–mTORC1 signaling is a critical determinant of ALD pathology; targeting SIRT1 and DEPTOR and selectively inhibiting mTORC1–S6K1 signaling may have therapeutic potential for treating ALD in humans. (Hepatology 2018).

Hepatic TRPC3 Loss Contributes to Chronic Alcohol Consumption-Induced Hepatic Steatosis and Liver Injury in Mice

Deficiency of NLR family member NLRC5 alleviates alcohol induced hepatic injury and steatosis by enhancing autophagy of hepatocytes

Phospholipase D2 Drives Cellular Lipotoxicity and Tissue Inflammation in Alcohol-Associated Liver Disease

Acid-sensing ion channel 1a promotes alcohol-associated liver disease in mice via regulating endoplasmic reticulum autophagy

Autophagy and exosomes coordinately mediate quercetin's protective effects on alcoholic liver disease

CD73-Adenosine A1R Axis Regulates the Activation and Apoptosis of Hepatic Stellate Cells Through the PLC-IP3-Ca2+/DAG-PKC Signaling Pathway

Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation

Disrupted subcellular distribution of aquaporin-3,8 and 9 promoted rat alcoholic liver disease

Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation

Preservation of Hepatocyte Nuclear Factor-4Α Contributes to the Beneficial Effect of Dietary Medium Chain Triglyceride on Alcohol-Induced Hepatic Lipid Dyshomeostasis in Rats.

Mesencephalic astrocyte-derived neurotrophic factor alleviates alcohol induced hepatic steatosis via activating Stat3-mediated autophagy

DEP Domain–containing Mtor–interacting Protein Suppresses Lipogenesis and Ameliorates Hepatic Steatosis and Acute‐on‐chronic Liver Injury in Alcoholic Liver Disease

Divergent Roles of Kupffer Cell TLR2/3 Signaling in Alcoholic Liver Disease and the Protective Role of EGCG.

Hepatocyte Toll-like Receptor 4 Regulates Alcoholic Fatty Liver Disease in Mice

Protocatechuic Acid-Mediated miR-219a-5p Activation Inhibits the p66shc Oxidant Pathway to Alleviate Alcoholic Liver Injury

Divergent Roles of Kupffer Cell TLR2/3 Signaling in Alcoholic Liver Disease and the Protective Role of EGCGSummary

Hepatic NCoR1 deletion exacerbates alcohol-induced liver injury in mice by promoting CCL2-mediated monocyte-derived macrophage infiltration

Transient receptor potential canonical 5 channels plays an essential role in hepatic dyslipidemia associated with cholestasis

AMPK-Regulated Autophagy Contributes to Ursolic Acid Supplementation-Alleviated Hepatic Steatosis and Liver Injury in Chronic Alcohol-Fed Mice

Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury

TLR9 Signaling Protects Alcohol-Induced Hepatic Oxidative Stress but Worsens Liver Inflammation in Mice